2019 PET/CT Imaging

This CME activity provides a clinical perspective of PET and PET/CT imaging. Basic to advanced applications of PET and PET/CT are put in the context of disease detection and treatment planning. All faculty have been chosen for their teaching ability, as well as for their clinical expertise.

This CME activity should benefit radiologists, oncologists, and nuclear medicine physicians. The course should also prove valuable for physicians who order these studies.

Educational Symposia

Physicians: Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Educational Symposia designates this enduring material for a maximum of 10.75 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credits awarded for these enduring activities are designated SA-CME" by the American Board of Radiology (ABR) and qualify toward fulfilling requirements for Maintenance of Certification (MOC) Part II: Lifelong Learning and Self-assessment.
All activity participants are required to take a written or online test in order to be awarded credit. (Exam materials, if ordered, will be sent with your order.) All course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.

AMA PRA Category 1 Credit(s)^TM for these programs may be claimed until September 30, 2022.
This CME activity was planned and produced by Educational Symposia, the leader in diagnostic imaging education since 1975.
This CME activity was planned and produced in accordance with the ACCME Essential Areas and Elements.

At the completion of this CME activity, subscribers should be able to:

• Apply state-of-the-art protocols to evaluate neurodegenerative disease and head and neck cancers to clinical practice.
• Optimize PET and PET-CT imaging protocols for the detection and follow up lung and breast cancer.
• Describe the advantages and pitfalls of PET and PET/CT.
• Differentiate normal variants and urgent findings on PET/CT.
• Discuss the utility of PET/CT when used to evaluate cardiac disease and gastrointestinal, thyroid and prostate cancers.

No special educational preparation is required for this CME activity